Answers are grounded in this paper and cite their sources.
There is insufficient evidence to recommend PTGS2 expression as a prognostic marker in patients with colorectal cancer. Furthermore, studies providing adjusted results are required.
No takes yet. Share an insight, caveat, or question.
Kunzmann et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: